
Defined Bioscience
United States · Biotech & life sciences · Pre-seed

Yo-Kai Express Inc.
United States · Agri & FoodTech · Series A
Compatibility /100
70/100
High potentialWhy talk
- Yo-Kai Express Inc. has raised about $19M — investor introductions are realistic.
- Defined Bioscience likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
- Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.
Score anatomy
Each segment is what one dimension adds, out of 100.
Score by goal
Dimension by dimension
Needs ↔ offers
17.5 / 35 pts
Yo-Kai Express Inc. can help Defined Bioscience.
- Defined Bioscience likely needs funding for the next round — Yo-Kai Express Inc. (United States, Series A, $19M raised, strong traction) can offer investor introductions (inferred from public profile).
Market bridge
3.5 / 10 pts
Distant markets.
- Both are based in United States: shared local customers, investors and ecosystem.
Customer potential
4.3 / 5 pts
Strong customer or channel potential.
- Yo-Kai Express Inc. has strong traction in a related sector (Agri & FoodTech): More than 250 ramen vending machines deployed (SFO, Tesla factories, Ueno station), according to Taiwan News 2025 — a proven go-to-market and customer relationships Defined Bioscience can learn from or tap.
Sector synergy
12.8 / 15 pts
Complementary sectors.
- Complementary sectors: Biotech & life sciences × Agri & FoodTech — room for a joint offer or co-selling.
Stage complementarity
31.5 / 35 pts
Strong mentoring / investor-intro potential.
- Yo-Kai Express Inc. has raised about $19M — investor introductions are realistic.
- Yo-Kai Express Inc. (Series A) is well ahead of Defined Bioscience (Pre-seed): mentoring and investor intros.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “Investment”: Needs ↔ offers 35, Market bridge 10, Customer potential 5, Sector synergy 15, Stage complementarity 35. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 65/100 — high from 50, medium from 36.